6th Annual ECD Medical Symposium Orlando, FL

Julio Hahdenberg, MD
Orlando Health & University of Florida Health Cancer Center
Orlando, Floride
April 1, 2018

Orlando Colloque médical Group Picture 2018

Symposium Summary

Approximately 44 medical professionals from six countries attended the Annual ECD Colloque médical in 2018. Ten oral abstracts were presented, along with an additional six poster presentations. As an invited speaker, Matthew Collin, delivered a talk titled “Erdheim-Chester Disease: Cancer, but not as we know it.” An evening reception provided time for discussions supporting current and future collaborations among this highly knowledgeable group of physicians and scientists, all interested in learning more about Erdheim-Chester Disease.

Témoignages des participants

“[The ECD Global Alliance] has helped me and my patients by] bringing experts together to make collaborative progress.”

– Ronald S. Go, MD, 2018 Attendee

Programs with Symposium Agenda

Presentations

AnimateurDiapositives de présentationEnglish Video
Julio Hajdenberg, MDWelcome AddressNot Available
Matthew Collin, docteur en médecine, docteur ès sciencesErdheim Chester Disease: Cancer, but not as we know it.Not Available
Eli L. Diamond, docteur en médecinePatient-reported outcomes in adults with Erdheim-Chester Disease: Early findings from the ECD RegistryNot Available
Benjamin Durham, docteur en médecineNovel Activating Mutations in CSF1R and Additional Receptor Tyrosine Kinases in Histiocytic NeoplasmsNot Available
Ran Weissman, M.ScThe role of microRNAs in the Pathogenesis of Erdheim-Chester Disease and their Potential Use as Biomarkers for Diagnosis and Prognosis of the DiseaseNot Available
Julien Haroche, docteur en médecine, docteur ès sciencesSlide deck not availableImaging aspect of cardiac involvement in Erdheim-Chester disease: cardiac CT and MRI of 188 patients
Gaurav Goyal, docteur en médecineTumor mutational burden and other immunotherapy markers in Erdheim-Chester disease and other histiocytic neoplasmsTumor mutational burden and other immunotherapy markers in Erdheim-Chester disease and other histiocytic neoplasms
Anaïs Roeser, MDAuto-immunity in L-group histiocytosesAuto-immunity in L-group histiocytoses
Roei Mazor, MDEfficacy of Dual BRAF/MAP2K1 Blockade in BRAF mutant Erdheim Chester Disease PatientsNon Vidéos available
Skand Shekhar, MDHypothyroidism in Erdheim-Chester Disease: Experience from the National Institutes of HealthNon Vidéos available
Gordon Ruan, MDAcute Pancreatitis from treatment with BRAF-inhibitors in patients with Erdheim-Chester DiseaseAcute Pancreatitis from treatment with BRAF-inhibitors in patients with Erdheim-Chester Disease
Eli L. Diamond, docteur en médecinePanel Discussion: TOXICITY OF ECD THERAPIESNon Vidéos available
Julio Hajdenberg, MDPanel Discussion: COMPLEX CASE STUDIESNon Vidéos available
Kathleen BrewerECDGA AnnouncementsNon Vidéos available

Photographies

Colloque médical

Medical Meeting